In Vivo Targeting of Clostridioides Difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
mBio - United States
doi 10.1128/mbio.00019-20
Full Text
Open PDFAbstract
Available in full text
Date
March 10, 2020
Authors
Publisher
American Society for Microbiology